NCT04567095View on ClinicalTrials.gov

A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 31, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Uterine Fibroids
Trial Locations (1)

92622

Clinical Trials Registry Team, Irvine

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY